VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AKBAAkebia Therapeutics, Inc.
$1.07$287M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAKBAPrice History

AKBA logoAkebia Therapeutics, Inc. (AKBA) Stock Price History

Historical prices from 2014 to 2026

$1.07+0.05  (+4.90%)close Jun 18
Returns
1M
+5.9%
3M
-25.7%
YTD
-31.0%
1Y
-69.9%
3Y
-1.8%
5Y
-21.9%
ATH$31.00Jun 2014-96.5%
ATL$0.24Oct 2022pre-split
Avg Vol (50D)4.9M/ day
52-Week Range$0.82 — $4.08
LowCurrent: $1.07High

Loading 10-year price history...

AKBA Historical Performance

1 YearTotal Return
-69.9%
Price: -69.9%
3 YearsTotal Return
-5.3%
CAGR: -1.8%
Price: -5.3%
5 YearsTotal Return
-70.9%
CAGR: -21.9%
Price: -70.9%
YTD
-31.0%

AKBA Annual Returns

Year-by-year price performance · 2014–2026

Best+99.0%2023
Worst-76.4%2022
Up years5/13
2014-56.4%
2015+12.3%
2016-17.1%
2017+41.6%
2018-63.1%
2019+9.0%
2020-55.8%
2021-22.9%
2022-76.4%
2023+99.0%
2024+49.6%
2025-15.3%
2026-15.5%
2014 annual price return
-56.4%
2015 annual price return
+12.3%
2016 annual price return
-17.1%
2017 annual price return
+41.6%
2018 annual price return
-63.1%
2019 annual price return
+9.0%
2020 annual price return
-55.8%
2021 annual price return
-22.9%
2022 annual price return
-76.4%
2023 annual price return
+99.0%
2024 annual price return
+49.6%
2025 annual price return
-15.3%
2026 annual price return
-15.5%
LessMore
Alpha vs S&P 500
1Y-94.9%
3Y-22.9%
5Y-35.1%

Price returns only.

Download Historical Data

3,082 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

AKBA Stock Price Trajectory (2014–2026)

As of June 22, 2026, Akebia Therapeutics, Inc. (AKBA) trades at $1.07, representing a -69.9% return over the past year. The stock has delivered a -70.9% total return over five years (-21.9% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $31.00 on June 20, 2014. From this peak, AKBA has corrected -96.5%, currently trading 37% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers FOLD (+152.9% 1Y), PTGX (+109.3% 1Y), and CYCN (+1.6% 1Y), AKBA has underperformed the peer group average. Compare AKBA vs FOLD →

AKBA Historical Price Data · from 2014

Rows 1–50 of 3,082
Date Open High Low Close Volume Change %
2026-06-181.051.081.001.0722.76M+4.90%
2026-06-170.991.050.981.023.95M+3.66%
2026-06-160.921.020.920.987.97M+4.83%
2026-06-150.930.940.900.945.49M+1.54%
2026-06-120.890.960.880.925.23M+2.79%
2026-06-110.860.930.840.9016.64M+3.04%
2026-06-100.920.960.820.877.15M-5.12%
2026-06-090.950.960.900.922.04M-1.67%
2026-06-080.950.970.900.942.48M+0.03%
2026-06-050.970.990.930.941.84M-3.61%
2026-06-040.971.000.960.972.37M+0.06%
2026-06-030.940.970.920.974.55M+3.56%
2026-06-021.011.020.910.947.02M-8.20%
2026-06-011.021.041.001.022.75M0.00%
2026-05-291.051.051.021.022.70M-2.86%
2026-05-281.041.071.011.052.93M+1.94%
2026-05-271.041.081.031.032.48M-0.96%
2026-05-261.021.081.021.042.96M+1.96%
2026-05-221.011.051.001.022.29M0.00%
2026-05-211.001.070.991.025.53M+0.99%
2026-05-200.901.010.901.0118.69M+12.84%
2026-05-191.001.000.880.9015.38M-11.38%
2026-05-181.061.081.001.016.55M-4.72%
2026-05-151.141.141.061.064.78M-6.19%
2026-05-141.181.191.131.134.05M-4.24%
2026-05-131.181.201.161.183.66M0.00%
2026-05-121.171.231.171.184.52M+1.29%
2026-05-111.151.231.141.174.51M+0.43%
2026-05-081.171.201.131.164.39M-1.69%
2026-05-071.151.231.131.1811.70M-20.27%
2026-05-061.481.531.461.483.68M+2.07%
2026-05-051.531.531.431.452.15M-3.33%
2026-05-041.411.531.411.503.26M+7.14%
2026-05-011.401.441.381.402.52M+1.45%
2026-04-301.391.411.361.381.07M+1.47%
2026-04-291.411.411.351.362.18M-4.23%
2026-04-281.421.461.411.421.51M0.00%
2026-04-271.431.511.421.422.66M-0.70%
2026-04-241.421.451.411.432.37M0.00%
2026-04-231.431.441.391.432.15M+0.70%
2026-04-221.421.451.401.421.49M+0.71%
2026-04-211.451.461.401.411.70M-1.40%
2026-04-201.411.451.401.431.95M+1.78%
2026-04-171.381.451.321.414.02M+4.07%
2026-04-161.541.561.351.355.19M-12.90%
2026-04-151.571.591.531.551.97M-0.64%
2026-04-141.481.561.471.562.21M+6.12%
2026-04-131.401.471.391.471.70M+5.00%
2026-04-101.411.461.391.401.96M-0.71%
2026-04-091.421.451.411.411.22M-1.40%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

AKBA — Frequently Asked Questions

Quick answers to the most common questions about buying AKBA stock.

How has AKBA stock performed recently?

AKBA declined -69.9% over the past year, below its 5-year annualized CAGR of -21.9%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is AKBA's all-time high price?

Akebia Therapeutics, Inc. reached $31.00 on 2014-06-20. The 52-week high is $4.08. Current 1-year return of -69.9% places the stock further from historical peaks.

Where can I download AKBA historical price data?

This page provides AKBA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.

442 data points · sampled from 3,082